The Online Investor

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Sun., Jan. 29, 6:29 PM

Slide #60. Elicio Therapeutics Angion Biomedica Corp

Acquirer: Elicio Therapeutics
Acquiree: Angion Biomedica Corp (NASDAQ:ANGN)
Details: Elicio Therapeutics, a privately-held, clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases, has entered into a definitive merger agreement with Angion Biomedica Corp (NASDAQ:ANGN) under which Elicio will merge with a wholly-owned subsidiary of Angion in an all-stock transaction. The combined company will continue under the Elicio Therapeutics name and will focus on advancing Elicio's proprietary lymph node-targeting Amphiphile (AMP) technology to develop immunotherapies, with a focus on ELI-002, a therapeutic cancer vaccine targeting mKRAS-driven tumors.



Open the ANGN Page at The Online Investor »

Company Name: 
Angion Biomedica Corp
Website: 
www.angion.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding ANGN: 
2
Total Market Value Held by ETFs: 
$389459
Total Market Capitalization: 
$19.00M
% of Market Cap. Held by ETFs: 
2.05%
 

Open the ANGN Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree ANGN Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.00 out of 4)
0th percentile
(ranked lower than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Mergers & Acquisitions Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2023, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.